BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. Enzyme replacement therapy (ERT) has demonstrated efficacy in slowing down disease progression in infants. Despite the large number of studies describing the effects of physical training in juvenile and adult late onset Pompe disease (LOPD). There are very few reports that analyze the benefits of respiratory muscle rehabilitation or training. METHODS: The effectiveness of respiratory muscle training was investigated using a specific appliance with adjustable resistance (Threshold). The primary endpoint was effect on respiratory muscular strength by measurements of MIP and MEP. Eight late-onset Pompe patients (aged 13 to 58 years; 4 female, 4 male) with respiratory muscle deficiency on functional respiratory tests were studied. All patients received ERT at the dosage of 20 mg/kg/every 2 weeks and underwent training with Threshold at specified pressures for 24 months. RESULTS: A significant increase in MIP was observed during the follow-up of 24 month: 39.6 cm H(2)O (+ 25.0%) at month 3; 39.5 cm H(2)O (+ 24.9%) at month 6; 39.1 cm H(2)O (+ 23.7%) at month 9; 37.3 cm H(2)O (+ 18.2%) at month 12; and 37.3 cm H(2)O (+ 17.8%) at month 24. Median MEP values also showed a significant increase during the first 9 months: 29.8 cm H(2)O, (+ 14.3%) at month 3; 31.0 cm H(2)O (+ 18.6) at month 6; and 29.5 cm H(2)O (+ 12.9) at month 9. MEP was then shown to be decreased at months 12 and 24; median MEP was 27.2 cm H(2)O (+ 4.3%) at 12 months and 26.6 cm H(2)O (+ 1.9%) at 24 months. The FVC remain stable throughout the study. CONCLUSION: An increase in respiratory muscular strength was demonstrated with Threshold training when used in combination with ERT.
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease.
阅读:3
作者:Jevnikar Mitja, Kodric Metka, Cantarutti Fabiana, Cifaldi Rossella, Longo Cinzia, Della Porta Rossana, Bembi Bruno, Confalonieri Marco
| 期刊: | Molecular Genetics and Metabolism Reports | 影响因子: | 1.900 |
| 时间: | 2015 | 起止号: | 2015 Oct 29; 5:67-71 |
| doi: | 10.1016/j.ymgmr.2015.09.007 | ||
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
